Related content

Recombinant tissue plasminogen activators (rtPA): A review

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 3, 2015-03 ,pp. : 274-285

John Wiley & Sons Inc

Access to resources Recommend Favorite

A synthetic peptide derived from staphylokinase enhances plasminogen activation by tissue‐type plasminogen activator

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 997-1006

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment of pediatric stroke with recombinant tissue plasminogen activator (rt-PA): a case report and review of the literature

By  

Canadian Journal of Emergency Medicine, Vol. 10, Iss. 6, 2008-11 ,pp. : 575-578

Cambridge University Press

Access to resources Recommend Favorite

Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear‐induced platelet activation

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 9, 2015-09 ,pp. : 1699-1708

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Plasminogen Activator System and Cancer

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 3-4, 2009-01 ,pp. : 184-194

Karger

Access to resources Recommend Favorite